Serum Anti-Mullerian Hormone, Follicle Stimulating Hormone and Antral Follicle Count Measurement as a Prediction for Pregnancy Rates in IVF/ICSI cycle

Predictive Value of Follicular Stimulating Hormone on Luteinizing Hormone Ratio for Ovarian Response to Simple Ovulation Induction in Patients with Polycystic Ovarian Syndrome

Using Anti-Müllerian Hormone and Serum Estradiol to Predict Ovarian Hyperstimulation Syndrome in Patients Using Antagonist Protocol During IVF/ICSI Cycles

SERUM ANTI- MULLERIAN HORMONE IS A BETTER PREDICTOR OF OVARIAN RESERVE AT THE EARLY FOLLICULAR PHASE.

Comparative Study Between Ovarian Response Prediction Index Versus Anti-Müllerian Hormone, Antral Follicular Count as Predictors of Ovarian Response in Women Undergoing IVF/ICSI C

Assessment of Follicular-Fluid Neurotrophin Levels as Predictor for Ovarian Reserve in Women Undergoing Assisted Reproductive Technology for Different Etiologies of Infertility

Anti-Müllerian Hormone Based Protocol Versus The Traditional Protocol For in-Vitro Fertilization/ Intracytoplasmic Sperm Injection: A Randomized Controlled Trial

Comparative Study of Anti-Mullerian Hormone, inhibin-B, and Three-Dimensional Ultrasound Determinants of Ovarian Reserve in Patients Undergoing ICSI

Correlation Between Serum Anti-Müllerian Hormone Levels and Antral Follicle Count in Prediction of Clinical Pregnancy in Women with Unexplained Infertility Undergoing ICSI Cycles

Comparison between Soft and Conventional Antagonist protocols for Estradiol Level and Number of Growing Follicles in Women of Poor Ovarian Response